Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Levers Health vs Push Health

Levers Health
Graded #469

Lower grade

vs+2.9000000000000057
Push Health
Graded #420

Higher grade

The verdict

Push Health takes it — 56.2/100 to 53.3/100.

Push Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePush Health +1
34
35
Dose & formulationPush Health +11
54
65
Clinical oversightEven
71
71
Labs & monitoringLevers Health +1
53
52
FulfillmentPush Health +5
62
67
Contract termsEven
55
55
Levers Health · left barPush Health · right bar

The numbers

MetricLevers HealthPush Health
WeighScore53.3/10056.2/100
GradeCC
Scorecard rank#469#420
Semaglutide$247/mo (1.25 mg dose, compounded)$950/mo (brand-name)
Tirzepatide$296/mo (5 mg dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Levers Health

Graded #469 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Push Health

Graded #420 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard